Manuel Dominguez
Advertisement
Articles by Manuel Dominguez
87 Elacestrant Plus Abemaciclib Combination in Patients With Estrogen Receptor-positive, HER2-Negative Advanced or Metastatic Breast Cancer
ByHope S. Rugo, MD,Sara M. Tolaney, MD, MPH,Nancy Chan,Erika P. Hamilton, MD,Eva Ciruelos,Ji-Yeon Kim,Elena López-Miranda,Elia Seguí,Neelima Vidula, MD,Joyce O’Shaughnessy, MD,Guiseppe Curigliano,Javier Cortés, MD,Alessandro Di Sanzo,Paula Muñoz Romero,Bartomeu Piza Vallespir,Manuel Dominguez,Kathy Puyana Theall,Alessandro Paoli,Monica Binaschi,Tomer Wasserman,Virginia Kaklamani, MD, DSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel Treatment Displays Tolerability in Relapsed/Refractory B-Cell ALL
2
MARIPOSA Final OS Results in Asia Population Yield Meaningful Improvement in EGFR NSCLC
3
3 Things You Should Know About Future Directions for BsAbs and ADCs in NSCLC
4
Surveying the Treatment Landscape for EGFR-Mutated Lung Cancer
5
